Download the TCR-based Therapies Summit Agenda

TCR Brochure Cover

 

A new wave of cell immunotherapy may be set to dominate solid tumor indications as TCR-based therapies are charged to invade the hostile microenvironment and tackle tumor indications.

This is your opportunity to gain the know-how across cell immunotherapy with in-depth discussion and insights from pioneers of this exciting new field.

Gain exclusive insights and network with industry leaders at the only TCR-Based Therapies Summit designed to optimize your TCR approach, enhance target selection & accelerate your therapy into the clinic, bringing life-saving therapy to patients who need it the most.

 

Download the Event Guide to discover:

  • Never-before seen data from novel companies
  • Collaboration with experts in 2 deep-dive workshop sessions on TCR preclinical development & Manufacturing and Logistics
  • 2 open panel discussions with industry leaders

And much more… Get your copy of the full event guide below!

Top Speakers Include:

Dolores Schendel

CEO

Medigene

Robert Hofmeister

Chief Scientific Officer

TCR2

Cheng Liu

Chief Executive Officer

Eureka Therapeutics

Gavin MacBeath

Chief Scientific Officer

TScan Therapeutics

Elisa Kieback

CEO

T-knife

David Scheinberg

Chairman, Molecular Pharmacology

Memorial Sloan Kettering Cancer Center

Steffen Walter

Chief Scientific Officer

Immatics US

Gang Zeng

Chief Executive Officer

T-Cure Biosciences Inc.